• FITC-Concanavalin A (ConA) Conjugate: Technical Application

  2026-06-04

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, facilitating reliable immunofluorescence staining and flow cytometry analysis in glycobiology research. This reagent should be strictly used for carbohydrate-binding workflows within its defined stability period and storage parameters, and is not appropriate for non-carbohydrate targets or unvalidated assay types.

• Capsazepine: TRPV1 Ion Channel Antagonist for Advanced Pain

  2026-06-04

  Capsazepine, a potent TRPV1 ion channel antagonist, enables researchers to dissect nociceptive and apoptotic mechanisms with high precision in both pain and cancer models. Its competitive inhibition profile and multi-channel selectivity make it an indispensable tool for advanced in vitro and ex vivo studies, especially where capsaicin analogs are required for functional assays.

• PDI Inhibition Enhances Panobinostat Efficacy in Myeloma Mod

  2026-06-03

  This study demonstrates that the protein disulfide isomerase (PDI) inhibitor LTI6426 significantly enhances the anti-myeloma activity of panobinostat at reduced doses in preclinical models. By converging on ER stress pathways, this combination offers a strategy to improve therapeutic outcomes while minimizing panobinostat-associated toxicity.

• SB743921 in Cancer Research: Precision KSP Inhibition and Be

  2026-06-03

  Explore SB743921, a potent kinesin spindle protein inhibitor, and its applications in advanced cancer research. Discover mechanistic insights, practical assay implications, and how this agent uniquely enables precision studies of cell cycle arrest in mitosis.

• Caspase-3 Colorimetric Assay Kit: Precision in Apoptosis Ana

  2026-06-02

  The Caspase-3 Colorimetric Assay Kit empowers researchers with rapid, quantitative detection of caspase-3 activity, streamlining apoptosis and cell signaling studies. Its straightforward workflow, high sensitivity, and proven reliability make it a standout tool—especially for complex immune and neurodegenerative disease models.

• Decoding mRNA Delivery: Advanced Assay Design with ARCA Cy5

  2026-06-02

  Explore the unique advantages of ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, for precision mRNA localization and translation efficiency assays. This article offers an in-depth assay design perspective, referencing cutting-edge lung delivery innovations and contrasting leading approaches.

• Poly (I:C): Synthetic Double-Stranded RNA Analog in Immunolo

  2026-06-01

  Poly (I:C), a synthetic double-stranded RNA analog, is redefining immune activation by enabling reliable TLR3-mediated interferon induction and dendritic cell maturation. This article unpacks advanced protocols, troubleshooting strategies, and cross-domain insights for maximizing Poly (I:C)'s impact in translational research.

• Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Ac

  2026-06-01

  This study introduces a stereoselective synthetic strategy to create α-hydroxy-β-amino acid derivatives of bestatin, yielding potent and selective nanomolar inhibitors for insulin-regulated aminopeptidase (IRAP). Structural and biochemical analyses reveal new determinants of selectivity, advancing rational inhibitor design for M1 aminopeptidases.

• Viperin Disrupts Coronavirus Replication via nsp8 Targeting

  2026-05-31

  The study elucidates how viperin inhibits coronavirus replication by directly binding to non-structural protein 8 (nsp8), thereby disrupting the assembly of the replication-transcription complex and impairing viral RNA synthesis. These findings clarify a conserved antiviral mechanism and inform targeted strategies for RNA virus replication inhibitor development.

• Rapamycin (Sirolimus): Decoding mTORC1 and Glucolipotoxicity

  2026-05-30

  Explore how Rapamycin (Sirolimus) advances mTORC1 research, with a distinct focus on integrated stress response and glucolipotoxicity in metabolic disease. Discover new assay insights and protocol parameters for translational applications.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-05-29

  The referenced study uncovers how certain dual-action kinase inhibitors not only block p38α MAP kinase activity but also enhance its dephosphorylation by stabilizing activation loop conformations accessible to phosphatases. This mechanistic insight offers a new avenue for developing kinase inhibitors with improved specificity and potency, impacting inflammatory signaling research.

• TJP3 Drives Immune Evasion and Chemoresistance in Breast Can

  2026-05-29

  This study integrates machine learning and multi-omics data to reveal that TJP3, an anoikis-related gene, mediates both T cell immune escape and chemoresistance in breast cancer. The results highlight the prognostic value of ARG-based stratification and suggest actionable markers for personalizing therapy response.

• L-NAME Hydrochloride: Unraveling NO Pathways in Vascular and

  2026-05-28

  Explore how L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) enables advanced dissection of nitric oxide signaling in vascular tone and inflammation studies. This article uniquely bridges mechanistic insight with practical assay design, revealing new perspectives beyond standard NOS inhibition protocols.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-05-28

  This study presents a tunable human intestinal organoid system that achieves precise control over the balance between stem cell self-renewal and differentiation. By leveraging small molecule pathway modulators, the authors create a platform with enhanced cellular diversity and proliferative capacity, addressing a longstanding challenge in organoid research.

• Actin–Myosin II Network Controls DEV Proliferation via VP26

  2026-05-27

  This study uncovers how the duck enteritis virus (DEV) protein VP26 interacts with host actin–myosin II cytoskeletal proteins, revealing a critical role for cytoskeletal dynamics in viral replication. Disruption of actin polymerization, including by Latrunculin A, significantly reduces DEV proliferation, offering new insights for antiviral research and cytoskeleton-targeted studies.

16285 records 1/1086 page Next 12345 下5页 Last page